Association of plasma level of growth differentiation factor-15 and clinical outcome after intraarterial thrombectomy.

[1]  Xiaoyu Dong,et al.  Association of serum growth differentiation factor 15 level with acute ischemic stroke in a Chinese population , 2019, The International journal of neuroscience.

[2]  Y. Béjot,et al.  Growth Differentiation Factor-15 (GDF-15) Is Associated With Mortality in Ischemic Stroke Patients Treated With Acute Revascularization Therapy , 2019, Front. Neurol..

[3]  Jiang He,et al.  Increased Growth Differentiation Factor 15 Is Associated with Unfavorable Clinical Outcomes of Acute Ischemic Stroke. , 2019, Clinical chemistry.

[4]  Ximing Nie,et al.  Futile Recanalization after Endovascular Therapy in Acute Ischemic Stroke , 2018, BioMed research international.

[5]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[6]  M. Casula,et al.  Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke , 2016, International journal of molecular sciences.

[7]  C. DeCarli,et al.  Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke , 2015, Stroke.

[8]  S. Banerjee,et al.  GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective , 2015, Journal of diabetes research.

[9]  A. Demchuk,et al.  Thrombectomy within 8 hours after symptom onset in ischemic stroke. , 2015, The New England journal of medicine.

[10]  H. Diener,et al.  Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. , 2015, The New England journal of medicine.

[11]  M. Krause,et al.  Endovascular therapy for ischemic stroke with perfusion-imaging selection. , 2015, The New England journal of medicine.

[12]  Eric E. Smith,et al.  Randomized assessment of rapid endovascular treatment of ischemic stroke. , 2015, The New England journal of medicine.

[13]  Hester F. Lingsma,et al.  A randomized trial of intraarterial treatment for acute ischemic stroke. , 2015, The New England journal of medicine.

[14]  Jian Wang,et al.  Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers , 2014, Molecular Neurobiology.

[15]  H. Jeong,et al.  Predictive factors for early clinical improvement after intra-arterial thrombolytic therapy in acute ischemic stroke. , 2014, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[16]  F. Sharp,et al.  Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Taura L. Barr,et al.  Admission neutrophil–lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy , 2013, Journal of NeuroInterventional Surgery.

[18]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[19]  O. Bang,et al.  Biomarkers for Stroke , 2013, Journal of stroke.

[20]  A. Alexandrov,et al.  Developing practice recommendations for endovascular revascularization for acute ischemic stroke , 2012, Neurology.

[21]  R. Wachter,et al.  Growth-differentiation factor-15 and functional outcome after acute ischemic stroke , 2012, Journal of Neurology.

[22]  R. Lichtinghagen,et al.  Growth Differentiation Factor 15 Plasma Levels and Outcome after Ischemic Stroke , 2011, Cerebrovascular Diseases.

[23]  K. Unsicker,et al.  Regulation of GDF-15, a distant TGF-β superfamily member, in a mouse model of cerebral ischemia , 2010, Cell and Tissue Research.

[24]  Jamie L Banks,et al.  Outcomes Validity and Reliability of the Modified Rankin Scale: Implications for Stroke Clinical Trials: A Literature Review and Synthesis , 2007, Stroke.

[25]  J. Broderick,et al.  Intracranial Hemorrhage Associated With Revascularization Therapies , 2007, Stroke.

[26]  R. Higashida,et al.  Trial Design and Reporting Standards for Intra-Arterial Cerebral Thrombolysis for Acute Ischemic Stroke , 2003, Stroke.

[27]  W. D. Fairlie,et al.  Expression of growth differentiation factor‐15/ macrophage inhibitory cytokine‐1 (GDF‐15/MIC‐1) in the perinatal, adult, and injured rat brain , 2001, The Journal of comparative neurology.

[28]  W. D. Fairlie,et al.  MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. , 1997, Proceedings of the National Academy of Sciences of the United States of America.